Cart
sales@molnova.com
Besifovir(b)
CAS No. 441785-25-7
Besifovir(b)( —— )
Catalog No. M20442 CAS No. 441785-25-7
Besifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 122 | In Stock |
|
| 5MG | 128 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 454 | In Stock |
|
| 100MG | 663 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBesifovir(b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBesifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
-
DescriptionBesifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number441785-25-7
-
Formula Weight299.22
-
Molecular FormulaC10H14N5O4P
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL?(835.51 mM)
-
SMILESNc1ncc2ncn(CC3(CC3)OCP(O)(O)=O)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mak L Y Seto W K Lai C L et al. Pharmacokinetic evaluation of besifovir for the treatment of HBV infection[J]. Expert Opinion on Drug Metabolism & Toxicology 2018 14(1):101-106.
molnova catalog
related products
-
Isothiafludine
Isothiafludine (NZ-4) is a novel HBV capsid assembly inhibitor that inhibits HBV replication through blocking pregenomic RNA encapsidation, suppresses HBV replication in HepG2.2.15 cells with IC50 of 1.33 uM.
-
Linvencorvir
Linvencorvir is a hepatitis B virus (HBV) core protein variant modifier used to treat chronic HBV infection.
-
?-Thujaplicinol
?-Thujaplicinol, a hydroxylated thujaplicinone isolated from western red cedar heartwood, has antiviral activity, inhibits hepatitis B virus replication by blocking viral ribonuclease H activity, and can be used in the study of viral infections.
